Skip to main content
AAN.com
Brief Communications
November 13, 2006

Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene

This article has been corrected.
VIEW CORRECTION
November 14, 2006 issue
67 (9) 1710-1712

Abstract

We screened 100 patients with inherited and sporadic lower motor neuron degeneration and identified three novel missense mutations in the glycyl-tRNA synthetase (GARS) gene. One mutation was in the anticodon binding domain and associated with onset in early childhood and predominant involvement of the lower limbs, thus extending the phenotype associated with GARS mutations.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Irobi J, De Jonghe P, Timmerman V. Molecular genetics of distal hereditary motor neuropathies. Hum Mol Genet 2004;13 Spec No 2:R195–R202.
2.
Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003;72:1293–1299.
3.
Sivakumar K, Kyriakides T, Puls I, et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005;128 (pt 10):2304–2314.
4.
Pearn J. Autosomal dominant spinal muscular atrophy: a clinical and genetic study. J Neurol Sci 1978;38:263–275.
5.
Del Bo R, Locatelli F, Corti S, et al. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 2006;66:752–754.
6.
Park SG, Ewalt KL, Kim S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 2005;30:569–574.
7.
Johanson K, Hoang T, Sheth M, Hyman LE. GRS1, a yeast tRNA synthetase with a role in mRNA 3′ end formation. J Biol Chem 2003;278:35923–35930.
8.
Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006;38:197–202.

Information & Authors

Information

Published In

Neurology®
Volume 67Number 9November 14, 2006
Pages: 1710-1712

Publication History

Published online: November 13, 2006
Published in print: November 14, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

P. A. James, MD
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).
M. Z. Cader, DPhil
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).
F. Muntoni, FMedSci
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).
A. -M. Childs, MD
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).
Y. J. Crow, PhD
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).
K. Talbot, DPhil
From the Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK (P.A.J., M.Z.C., K.T.); Dubowitz Neuromuscular Centre, Imperial College London, London, UK (F.M.); Department of Pediatric Neurology, Leeds General Infirmary, Leeds, UK (A.-M.C.); and Yorkshire Regional Genetic Service, St James’s University Hospital, Leeds, UK (Y.J.C.).

Notes

Address correspondence and reprint requests to Dr. Kevin Talbot, Henry Wellcome Building for Gene Function, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 1LF, UK; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Dominant aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models, Frontiers in Neuroscience, 17, (2023).https://doi.org/10.3389/fnins.2023.1182845
    Crossref
  2. Clinical, Genetic, and Disability Profile of Pediatric Distal Hereditary Motor Neuropathy, Neurology, 96, 3, (e423-e432), (2023)./doi/10.1212/WNL.0000000000011054
    Abstract
  3. Large-scale detection and characterization of interchromosomal rearrangements in normozoospermic bulls using massive genotype and phenotype data sets, Genome Research, 33, 6, (957-971), (2023).https://doi.org/10.1101/gr.277787.123
    Crossref
  4. Aminoacyl-tRNA synthetases in human health and disease, Frontiers in Physiology, 13, (2022).https://doi.org/10.3389/fphys.2022.1029218
    Crossref
  5. A missense, loss-of-function YARS1 variant in a patient with proximal-predominant motor neuropathy , Molecular Case Studies, 8, 7, (a006246), (2022).https://doi.org/10.1101/mcs.a006246
    Crossref
  6. Pathogenic missense variants altering codon 336 of GARS1 lead to divergent dominant phenotypes , Human Mutation, 43, 7, (869-876), (2022).https://doi.org/10.1002/humu.24372
    Crossref
  7. Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease, Frontiers in Cell and Developmental Biology, 9, (2021).https://doi.org/10.3389/fcell.2021.624823
    Crossref
  8. Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase, Biochemistry (Moscow), 86, S1, (S12-S23), (2021).https://doi.org/10.1134/S0006297921140029
    Crossref
  9. tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase, Science, 373, 6559, (1161-1166), (2021).https://doi.org/10.1126/science.abb3356
    Crossref
  10. AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY/+ mice , Brain Communications, 3, 4, (2021).https://doi.org/10.1093/braincomms/fcab252
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share